Agenda for Meeting Six: August 29-30, 2011, in Washington, D.C.

Ritz Carlton Hotel
1150 22nd Street, NW
Washington, DC  20037

Monday, August 29               

1:00 – 1:15 p.m. Welcome and Opening Remarks

Amy Gutmann, Ph.D.
Commission Chair

James Wagner, Ph.D.
Commission Vice-Chair

1:15 – 2:00 p.m.  Session 1: Historical Investigation – Research Details

Commission Members                                              

2:00 – 3:00 p.m.  Session 2: Historical Investigation – Ethics Standards and Practices

Commission Members                                           

3:00 – 3:15 p.m.  Conclusions on the Ethics of the Experiments                                            

Amy Gutmann, Ph.D.
James Wagner, Ph.D.                                       

Tuesday, August 30

9:00 – 9:15 a.m. Opening Remarks                                  

Amy Gutmann, Ph.D.
James Wagner, Ph.D.

9:15 – 9:45 a.m.  Session 3: Human Subjects Protection Reform

Ezekiel J. Emanuel, M.D., Ph.D.
Former Chief, Clinical Center Department of Bioethics
National Institutes of Health

9:45 – 10:30 a.m. Session 4: International Research Panel Results and Discussion                  

Nelson Michael, M.D., Ph.D.
Commission Member

Christine Grady, R.N., Ph.D.
Commission Member       

10:30 – 10:45 a.m. Break                                                             

10:45 – 11:45 a.m.  Session 5: Community Engagement – Needs, Models and U.S. Actions                    

Carletta Tilousi
Member, Havasupai Tribal Council
Havasupai Tribe

Mitchell Warren
Executive Director, AVAC: Global Advocacy for HIV Prevention                      

Roger I. Glass, M.D., Ph.D.
Director, Fogarty International Center
Associate Director for International Research
National Institutes of Health      

11:45 a.m. – 12:15 p.m.  Session 6: Staff Report on Current Scientific Studies Supported by the Federal Government

Jeremy Sugarman, M.D., M.P.H., M.A.
Senior Advisor

Michelle Groman, J.D.
Senior Policy & Research Analyst

12:15 – 1:15 p.m.  Lunch Break

1:15 – 2:00 p.m.  Session 7: Trial Design and International Standards

Ruth Macklin, Ph.D.
Professor of Bioethics, Department of Epidemiology and Population Health
Albert Einstein College of Medicine

Robert Temple, M.D.
Deputy Center Director for Clinical Science
Center for Drug Evaluation and Research
Acting Director, Office of Drug Evaluation I
U.S. Food and Drug Administration (FDA)

2:00 – 2:15 p.m.  Concluding Remarks

Amy Gutmann, Ph.D.
James Wagner, Ph.D.



This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.